New cyclolignans from Origanum glandulosum active against β-amyloid aggregation

Records of Natural Products

Volumn 8, Issue 3, 2014, Pages 208-216

  Basli, Abdelkader ^a,b   Delaunay, Jean Claude ^a   Pedrot, Eric ^a   Bernillon, Stéphane ^c   Madani, Khodir ^b   Monti, Jean Pierre ^a   Mérillon, Jean Michel ^a   Chibane, Mohamed ^d   Richard, Tristan ^a  

^a Bordeaux Segalen University   (France)

^b UNIVERSITY OF BEJAIA   (Algeria)

^c Univ Bordeaux   (France)

^d UNIVERSITY OF BOUIRA   (Algeria)

Author keywords

Cyclolignans; NMR; Oregano; Origanum glandulosum; Amyloid aggregation

Indexed keywords

AMYLOID BETA PROTEIN; CURCUMIN; CYCLOLIGNAN DERIVATIVE; GLOBOIDNAN A; GLOBOIDNAN B; ORIGANUM GLANDULOSUM EXTRACT; PLANT EXTRACT; PLANT MEDICINAL PRODUCT; ROSMARINIC ACID; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ISOLATION; DRUG STRUCTURE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IC 50; IN VITRO STUDY; INHIBITION KINETICS; MASS SPECTROMETRY; NEUROPROTECTION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; ORIGANUM; ORIGANUM GLANDULOSUM; PROTEIN AGGREGATION;

EID: 84899754508     PISSN: None     EISSN: 13076167     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. J. H. Ietswaart (1980). A taxonomic revision of the genus Origanum (Labiatae), Le Hague: Leiden Botanical Series 4, Leiden University Press.
2. M. Skoula and J. B. Harborne (2002). Taxonomy and Chemistry of Oreganum. In: Oregano: The genera Origanum and Lippia, ed: S. E. Kintzios, Taylor & Francis (CRC Press), New York, pp. 67-108.
3. F. E. Babili, J. Bouajila, J. P. Souchard, C. Bertrand, F. Bellvert, I. Fouraste, C. Moulis and A. Valentin (2011). Oregano: Chemical analysis and evaluation of its antimalarial, antioxidant, and cytotoxic activities, J. Food Sci. 76, C512-C518.
4. V. Exarchou, N. Nenadis, M. Tsimidou, I. P. Gerothanassis, A. Troganis and D. Boskou (2002). Antioxidant activities and phenolic composition of extracts from Greek Oregano, Greek Sage, and Summer Savory, J. Agric. Food Chem. 50: 5294-5299.
5. V. Exarchou, M. Godejohann, T. A. van Beek, I. P. Gerothanassis and J. Vervoort (2003). LC UV-Solid-Phase Extraction-NMR-MS combined with a cryogenic flow probe and its application to the identification of compounds present in Greek Oregano, Anal. Chem. 75, 6288-6294.
6. J. M. Orgogozo, J. F. Dartigues, S. Lafont, L. Letenneur, D. Commenges, R. Salamon, S. Renaud and M. B. Breteler (1997). Wine consumption and dementia in the elderly: A prospective community study in the Bordeaux area, Nat. Rev. Neurol. 153, 185-192.
7. V. Deschamps, P. Barberger-Gateau, E. Peuchant and J. M. Orgogozo (2001). Nutritional factors in cerebral aging and dementia: epidemiological arguments for a role of oxidative stress, Neuroepidemiology 20, 7-15.
8. C. Ramassamy (2006). Emerging role of polyphenolic compounds in the treatment of neurodegenerative diseases: A review of their intracellular targets, Eur. J. Pharmacol. 545, 51-64.
9. A. Ebrahimi and H. Schluesener (2012). Natural polyphenols against neurodegenerative disorders: potentials and pitfalls, Ageing Res. Rev. 11, 329-345.
10. T. Hamaguchi, K. Ono, A. Murase and M. Yamada (2009). Phenolic compounds prevent Alzheimer's pathology through different effects on the amyloid-ppaggregation pathway, Am. J. Pathol. 175, 2557-2565.
11. M. Petersen and M. S. J. Simmonds (2003). Rosmarinic acid, Phytochem. 62, 121-125.
12. C. Pereira, P. Agostinho, P. I. Moreira, S. M. Cardoso and C. R. Oliveira (2005). Alzheimer's Diseaseassociated neurotoxic mechanisms and neuroprotective strategies. Curr. Drug Targets 4, 383-403.
13. K. Ono, K. Hasegawa, H. Naiki and M. Yamada (2004). Curcumin has potent anti-amyloidogenic effects for Alzheimer's f-amyloid fibrils in vitro. J. Neurosci. Res. 75, 742-750.
14. Y. Porat, A. Abramowitz and E. Gazit (2006). Inhibition of amyloid fibril formation by polyphenols: structural similarity and aromatic interactions as a common inhibition mechanism. Chem. Biol. Drug Des. 67, 27-37.
15. C. Rivière, T. Richard, X. Vitrac, J. M. Mérillon, J. Valls and J. P. Monti (2008). New polyphenols active on o-amyloid aggregation. Bioorg. Med. Chem. Lett. 18, 828-831.
16. S. Bastianetto, Y. Dumont, Y. Han and R. Quirion (2009). Comparative neuroprotective properties of stilbene and catechin analogs: Action via a plasma membrane receptor site CNS Neurosci. Ther. 15, 76-83.
17. T. Richard, P. Poupard, M. Nassra, Y. Papastamoulis, M. L. Iglésias, S. Krisa, P. Waffo-Teguo, J. M. Mérillon and J. P. Monti (2011). Protective effect of M-viniferin on--amyloid peptide aggregation investigated by electrospray ionization mass spectrometry. Bioorg. Med. Chem. 19, 3152 3155.
18. K. Ono, L. Li, Y. Takamura, Y. Yoshiike, L. Zhu, F. Han, X. Mao, T. Ikeda, J. I. Takasaki, H. Nishijo, A. Takashima, D. B. Teplow, M. G. Zagorski and M. Yamada (2012). Phenolic compounds prevent amyloid a-protein oligomerization and synaptic dysfunction by site specific binding. J. Biol. Chem. 287, 14631-14643.
19. C. Rivière, T. Richard, L. Quentin, S. Krisa, J. M. Mérillon and J. P. Monti (2007). Inhibitory activity of stilbenes on Alzheimer's e-amyloid fibrils in vitro. Bioorg. Med. Chem. 15, 1160-1167.
20. H. Tazaki, D. Taguchi, T. Hayashida and K. Nabeta (2001). Stable isotope labeling studies on oxidative coupling of caffeic acid via o-quinone. Biosci. Biotechnol. Biochem. 65, 2613-2621.
21. M. Wang, J. Li, M. Rangarajan, Y. Shao, E. J. LaVoie, T. C. Huang and C. T. Ho (1998). Antioxidative Phenolic Compounds from Sage (Salvia officinalis). J. Agric. Food Chem. 46, 4869-4873.
22. Y. Lu and L. Y. Foo (1999). Rosmarinic acid derivatives from Salvia officinalis. Phytochem. 51, 91-94.
23. S. P. B. Ovenden, J. Yu, S. S. San Wan, G. Sberna, R. M. Tait, D. Rhodes, S. Cox, J. Coates, N. G. Walsh and B. M. Meurer-Grimes (2004). Globoidnan A: A lignan from Eucalyptus globoidea inhibits HIV integrase. Phytochem. 65, 3255-3259.
24. C. J. Pike, A. J. Walencewicz-Wasserman, J. Kosmoski, D. H. Cribbs, C. G. Glabe and C. W. Cotman (1995). Structure activity analyses of (-amyloid peptides: contributions of the l25-35 region to aggregation and neurotoxicity. J. Neurochem. 64, 253-265.
25. C. Rivière, Y. Papastamoulis, P. Y. Fortin, N. Delchier, S. Andriamanarivo, P. Waffo-Teguo, G. D. W. F. Kapche, H. Amira-Guebalia, J. C. Delaunay, J. M. Mérillon, T. Richard and J. P. Monti (2010). New stilbene dimers against amyloid fibril formation. Bioorg. Med. Chem. Lett. 20, 3441-3443.
26. T. Iuvone, D. De Filippis, G. Esposito, A. D'Amico and A. A. Izzo (2006). The spice sage and its active ingredient Rosmarinic Acid protect PC12 cells from amyloid-beta peptide-induced neurotoxicity, J. Pharmacol. Exp. Ther. 317, 1143-1149.